Q SYNTHESIS LLC
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates

Advances in lung cancer immunotherapy from AACR (published in NEJM)

4/17/2018

 
At the American Association for Cancer Research (AACR) meeting, several major updates in lung cancer immunotherapy studies were announced and thee articles were concurrently published in the NEJM:

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

​April 16, 2018
Picture

Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
Home

About

Contact
​

​Publications
Picture
​Quality Improvement 
​
Systems Thinking 

​Implementation Science 

​Updates
www.qsynthesis.com
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates